15-Year watch: tracking the Long-Term safety of advanced blood cancer treatments
Disease control
Recruiting now
This study will follow patients for 15 years after they received a Galapagos CAR T-cell therapy for blood cancers. The goal is to monitor for any long-term side effects and see how well the treatment continues to work over time. It will include about 546 people who have already r…
Phase: PHASE3 • Sponsor: Galapagos NV • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC